 BOSTON--BUSINESS WIRE--- KRTX--Karuna Therapeutics, Inc. NASDAQ: KRTX, a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that senior management will present at the following upcoming virtual investor conferences: Oppenheimer 32nd Annual Healthcare Conference Date: Tuesday, March 15, 2022 Time: 9:20 a.m. ET 1st Annual Needham Virtual Neuroscience Forum Date: Wednesday, March 